Docetaxel in the integrated management of prostate cancer. Current applications and future promise. [electronic resource]
- Oncology (Williston Park, N.Y.) Jun 2002
- 63-72 p. digital
Publication Type: Journal Article; Review
0890-9091
Antineoplastic Agents, Phytogenic--adverse effects Antineoplastic Combined Chemotherapy Protocols--therapeutic use Chemotherapy, Adjuvant Clinical Trials as Topic Docetaxel Forecasting Humans Male Neoadjuvant Therapy Paclitaxel--adverse effects Prostatic Neoplasms--drug therapy Recurrence Taxoids